What is Pantoprazolo Almus used for?

Pantoprazolo Almus

Active Ingredient:: Pantoprazole Sodium Sesquihydrate
Origin:: EU

Pantoprazolo Almus (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazolo Almus, is a proton pump inhibitor presented as a strength‑unknown oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and related acid‑related disorders in adults.

GNH India supplies Pantoprazolo Almus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Almus S.R.L.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pantoprazolo Almus is a proton pump inhibitor that acts on the gastric acid secretion pathway to manage several acid‑related disorders.

Gastro‑oesophageal reflux disease (GERD): helps heal erosive esophagitis and relieve heartburn symptoms.
Erosive esophagitis: promotes healing of the damaged esophageal lining.
NSAID‑induced gastric ulcer: reduces acid exposure to support ulcer healing.
Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.

How It Works

Pantoprazole sodium sesquihydrate irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly lowers gastric acidity, providing prolonged acid suppression throughout the dosing interval.

Side Effects

Pantoprazolo Almus may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

Headache: mild to moderate intensity.
Diarrhea: usually self‑limiting.
Nausea: occasional and transient.
Abdominal pain: mild discomfort.
Flatulence: excess gas.
Constipation: infrequent.

Serious or Rare Side Effects

Clostridioides difficile infection: severe colitis risk.
Acute interstitial nephritis: kidney inflammation.
Severe hypersensitivity: rash, angioedema, anaphylaxis.
Low magnesium levels: may cause muscle cramps or arrhythmias.
Fracture risk: long‑term use linked to reduced bone density.
Liver enzyme elevation: potential hepatic impact.

Precautions & Warnings

Before starting Pantoprazolo Almus, consider the following safety points:

Assess renal function: dose adjustment may be needed in severe impairment.
Review liver status: use with caution in hepatic disease.
Monitor electrolytes: prolonged therapy can affect magnesium and potassium.
Evaluate infection risk: PPIs may increase susceptibility to gastrointestinal infections.
Consider bone health: long‑term use may affect calcium balance.
Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Pantoprazolo Almus can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid)

Ketoconazole oral suspension: reduced absorption due to higher gastric pH.
Atazanavir: markedly decreased plasma levels, risking treatment failure.
Clopidogrel: diminished antiplatelet effect, potentially increasing cardiovascular risk.

Moderate Interactions (Monitor Closely)

Warfarin: possible increase in INR, requiring closer monitoring.
Methotrexate: reduced renal clearance may raise toxicity risk.
Digoxin: slight increase in serum concentrations.
Mycophenolate mofetil: decreased exposure, may require dose adjustment.

Frequently Asked Questions

Pantoprazolo Almus contains pantoprazole, a proton pump inhibitor that is prescribed to lower stomach acid. It is commonly used to treat gastro‑oesophageal reflux disease, erosive esophagitis, NSAID‑induced gastric ulcers and Zoll‑‑

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 13 Oct 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.